Difference between revisions of "LINC01503"
Chunlei Yu (talk | contribs) (Created page with "==Annotated Information== ===Approved Symbol=== LINC01503 ===Approved Name=== long intergenic non-protein coding RNA 1503 ===Previous Symbols=== _ ===Synonyms=== lnc-PPP2R4-5 ...") |
|||
| Line 1: | Line 1: | ||
==Annotated Information== | ==Annotated Information== | ||
| − | === | + | ===Name=== |
| − | LINC01503 | + | Approved Symbol: LINC01503 |
| − | + | ||
| − | long intergenic non-protein coding RNA 1503 | + | Approved Name:long intergenic non-protein coding RNA 1503 |
| − | + | ||
| − | + | Synonyms:lnc-PPP2R4-5 | |
| − | + | ||
| − | lnc-PPP2R4-5 | + | RefSeq ID:NR_120685 |
| − | + | ||
| − | + | Ensembl ID:ENSG00000233901 | |
| − | + | ||
| − | + | LncBook ID: [https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNT0289110] | |
| − | + | ||
| − | + | ===Function=== | |
| − | + | LINC01503 is involved in cisplatin resistance, which is under epegenetic (DNA methylation) regulation.<ref name="ref1" /> | |
| − | + | ||
| − | === | ||
| − | |||
===Sequence=== | ===Sequence=== | ||
>gi|649572632|ref|NR_120685.1| Homo sapiens long intergenic non-protein coding RNA 1503 (LINC01503), transcript variant 1, long non-coding RNA | >gi|649572632|ref|NR_120685.1| Homo sapiens long intergenic non-protein coding RNA 1503 (LINC01503), transcript variant 1, long non-coding RNA | ||
<dnaseq>ATTCGAGGCGACGGGCTCCGGGCCCTGATAGATGGGGTGCGGGGACGGAGACAAATGACGGCCTTTGGGCTCGGAATACCCACCTTTCTGGTAATGCAGCCCAGCGGGTCCCAGCCTCGTTTTCCAGCCCTCACTCAAAATGGAGTCGCTCTGGTTCGAACGCCTCTGACAAGTGTGTACCTACGTGTCAGGCCCATCCTTCCTGCAGGCCTTTGTCTTGGTGTCACCCTGCCTGAGCTGGCCCCAACCACAGTAGCAACAGTGATGCTGATGTGTGACTGCTGCCAGGAGCCTGCTCACATGACCGTGTGGAGAAAGTTCTTTCCCTGAGGACCATCTGGAGTGGACGCGTGCACTACCCCTCTCTGAATACACCCTCCCCACGAGGCCCTCTGGAGCATCCTGTAGAGCCAGCCCCTACCCAGAGACCCTGAGCCCAGAGAATGCGCTGGGTGGTGAGCCTGGGGACGAATGCAGAGCCCTAGGTCTCCTCTCCAGAAAGACCGGATTTTGCCATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTCAAGTGATCCACCTGCCTCGGCCTCCCAAAGTGCAGGGATTACAGGTGTGAGCCACTGCACCCGGCCTCAGGCAGGTATTTTTACCAGCCGAATACTCTTGCACTGTGCACTCTTCGTGTTCATCATCAGTCCCCCGGATGGGTGTTTAAGGCATTTCCAAAGCTCTGTTATTAAAAACACGATGCAATGAGTTTCTTTCAGCA</dnaseq> | <dnaseq>ATTCGAGGCGACGGGCTCCGGGCCCTGATAGATGGGGTGCGGGGACGGAGACAAATGACGGCCTTTGGGCTCGGAATACCCACCTTTCTGGTAATGCAGCCCAGCGGGTCCCAGCCTCGTTTTCCAGCCCTCACTCAAAATGGAGTCGCTCTGGTTCGAACGCCTCTGACAAGTGTGTACCTACGTGTCAGGCCCATCCTTCCTGCAGGCCTTTGTCTTGGTGTCACCCTGCCTGAGCTGGCCCCAACCACAGTAGCAACAGTGATGCTGATGTGTGACTGCTGCCAGGAGCCTGCTCACATGACCGTGTGGAGAAAGTTCTTTCCCTGAGGACCATCTGGAGTGGACGCGTGCACTACCCCTCTCTGAATACACCCTCCCCACGAGGCCCTCTGGAGCATCCTGTAGAGCCAGCCCCTACCCAGAGACCCTGAGCCCAGAGAATGCGCTGGGTGGTGAGCCTGGGGACGAATGCAGAGCCCTAGGTCTCCTCTCCAGAAAGACCGGATTTTGCCATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTCAAGTGATCCACCTGCCTCGGCCTCCCAAAGTGCAGGGATTACAGGTGTGAGCCACTGCACCCGGCCTCAGGCAGGTATTTTTACCAGCCGAATACTCTTGCACTGTGCACTCTTCGTGTTCATCATCAGTCCCCCGGATGGGTGTTTAAGGCATTTCCAAAGCTCTGTTATTAAAAACACGATGCAATGAGTTTCTTTCAGCA</dnaseq> | ||
| + | |||
| + | ==Labs working on this lncRNA== | ||
| + | *Cancer Epigenetics Laboratory, INGEMM , La Paz University Hospital , Madrid , Spain. | ||
| + | |||
| + | ==References== | ||
| + | <references> | ||
| + | <ref name="ref1"> Vera O, Rodriguez-Antolin C, de Castro J, Karreth FA, Sellers TA, Ibanez de | ||
| + | Caceres I. An epigenomic approach to identifying differential overlapping and | ||
| + | cis-acting lncRNAs in cisplatin-resistant cancer cells. Epigenetics. | ||
| + | 2018;13(3):251-263. doi: 10.1080/15592294.2018.1436364. Epub 2018 Apr 2. PubMed | ||
| + | PMID: 29436261; PubMed Central PMCID: PMC5997141. | ||
| + | </ref>(1) | ||
| + | </references> | ||
Latest revision as of 12:00, 11 August 2019
Contents
Annotated Information
Name
Approved Symbol: LINC01503
Approved Name:long intergenic non-protein coding RNA 1503
Synonyms:lnc-PPP2R4-5
RefSeq ID:NR_120685
Ensembl ID:ENSG00000233901
LncBook ID: HSALNT0289110
Function
LINC01503 is involved in cisplatin resistance, which is under epegenetic (DNA methylation) regulation.[1]
Sequence
>gi|649572632|ref|NR_120685.1| Homo sapiens long intergenic non-protein coding RNA 1503 (LINC01503), transcript variant 1, long non-coding RNA
000001 ATTCGAGGCG ACGGGCTCCG GGCCCTGATA GATGGGGTGC GGGGACGGAG ACAAATGACG GCCTTTGGGC TCGGAATACC 000080
000081 CACCTTTCTG GTAATGCAGC CCAGCGGGTC CCAGCCTCGT TTTCCAGCCC TCACTCAAAA TGGAGTCGCT CTGGTTCGAA 000160
000161 CGCCTCTGAC AAGTGTGTAC CTACGTGTCA GGCCCATCCT TCCTGCAGGC CTTTGTCTTG GTGTCACCCT GCCTGAGCTG 000240
000241 GCCCCAACCA CAGTAGCAAC AGTGATGCTG ATGTGTGACT GCTGCCAGGA GCCTGCTCAC ATGACCGTGT GGAGAAAGTT 000320
000321 CTTTCCCTGA GGACCATCTG GAGTGGACGC GTGCACTACC CCTCTCTGAA TACACCCTCC CCACGAGGCC CTCTGGAGCA 000400
000401 TCCTGTAGAG CCAGCCCCTA CCCAGAGACC CTGAGCCCAG AGAATGCGCT GGGTGGTGAG CCTGGGGACG AATGCAGAGC 000480
000481 CCTAGGTCTC CTCTCCAGAA AGACCGGATT TTGCCATGTT GGCCAGGCTG GTCTTGAACT CCTGACCTCA AGTGATCCAC 000560
000561 CTGCCTCGGC CTCCCAAAGT GCAGGGATTA CAGGTGTGAG CCACTGCACC CGGCCTCAGG CAGGTATTTT TACCAGCCGA 000640
000641 ATACTCTTGC ACTGTGCACT CTTCGTGTTC ATCATCAGTC CCCCGGATGG GTGTTTAAGG CATTTCCAAA GCTCTGTTAT 000720
000721 TAAAAACACG ATGCAATGAG TTTCTTTCAG CA
000081 CACCTTTCTG GTAATGCAGC CCAGCGGGTC CCAGCCTCGT TTTCCAGCCC TCACTCAAAA TGGAGTCGCT CTGGTTCGAA 000160
000161 CGCCTCTGAC AAGTGTGTAC CTACGTGTCA GGCCCATCCT TCCTGCAGGC CTTTGTCTTG GTGTCACCCT GCCTGAGCTG 000240
000241 GCCCCAACCA CAGTAGCAAC AGTGATGCTG ATGTGTGACT GCTGCCAGGA GCCTGCTCAC ATGACCGTGT GGAGAAAGTT 000320
000321 CTTTCCCTGA GGACCATCTG GAGTGGACGC GTGCACTACC CCTCTCTGAA TACACCCTCC CCACGAGGCC CTCTGGAGCA 000400
000401 TCCTGTAGAG CCAGCCCCTA CCCAGAGACC CTGAGCCCAG AGAATGCGCT GGGTGGTGAG CCTGGGGACG AATGCAGAGC 000480
000481 CCTAGGTCTC CTCTCCAGAA AGACCGGATT TTGCCATGTT GGCCAGGCTG GTCTTGAACT CCTGACCTCA AGTGATCCAC 000560
000561 CTGCCTCGGC CTCCCAAAGT GCAGGGATTA CAGGTGTGAG CCACTGCACC CGGCCTCAGG CAGGTATTTT TACCAGCCGA 000640
000641 ATACTCTTGC ACTGTGCACT CTTCGTGTTC ATCATCAGTC CCCCGGATGG GTGTTTAAGG CATTTCCAAA GCTCTGTTAT 000720
000721 TAAAAACACG ATGCAATGAG TTTCTTTCAG CA
Labs working on this lncRNA
- Cancer Epigenetics Laboratory, INGEMM , La Paz University Hospital , Madrid , Spain.
References
- ↑ Vera O, Rodriguez-Antolin C, de Castro J, Karreth FA, Sellers TA, Ibanez de Caceres I. An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells. Epigenetics. 2018;13(3):251-263. doi: 10.1080/15592294.2018.1436364. Epub 2018 Apr 2. PubMed PMID: 29436261; PubMed Central PMCID: PMC5997141.
